Patient-reported outcomes: an overview of applications-Reference-Cited by-同舟云学术

Patient-reported outcomes: an overview of applications

Published:2022-08-08 Issue:2 Volume:2 Page:1-7
ISSN:2782-3784
Container-title:Real-World Data & Evidence
language:
Short-container-title:MyRWD

Author:

Mukhina S. M.¹^ORCID,Orlova E. V.¹^ORCID

Affiliation:

1. FSBEI HE I. P. Pavlov SPbSMU MOH Russia

Abstract

This article focuses on patient-reported outcomes (PROs) and their role in decision making in patient-centred healthcare. Let»s look at how PRO can be used in clinical trials, to evaluate the effectiveness of treatment, to validate a claim on a product label by regulatory authorities, and in clinical practice to monitor patient conditions.

Publisher

Publishing House OKI

Reference16 articles.

1. U. S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U. S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U. S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006 Oct 11;4:79. doi: 10.1186 / 1477-7525-4-79

2. Horn ME, Reinke EK, Mather RC, O'Donnell JD, George SZ. Electronic health Record-integrated approach for collection of patient-reported outcome measures: a retrospective evaluation. BMC Health Serv Res. 2021;21 (1):626. doi: 10.1186 / s12913-021-06626-7

3. Real-world data. Kolbin A.S. et al. — M.: Publishing House OKI: Buki Vedi, 2020. — 208 p.: ill. ISBN 978-5-4465-2902-5.

4. Patient-reported outcome measures: use in medical product development to support labeling claims: Guidance for industry. US Food and Drug Administration. https://www.fda.gov / regulatory-information / search-fda-guidancedocuments / patient-reported-outcome-measuresuse-medical-product-development-supportlabeling-claims. Published December 2009. Accessed December 28, 2020.

5. Wong RL, Morgans AK. Integration of Patient Reported Outcomes in Drug Development in Genitourinary Cancers. Curr Oncol Rep. 2020;22 (3):21. doi: 10.1007 / s11912-020-0890-3

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospects for the use of telemedicine technologies based on artificial intelligence during medical examination;Meditsinskiy sovet = Medical Council;2024-05-13

2. Effectiveness of osteosynthesis with flexible titanium rods in the long-term treatment of femoral fractures in children aged 0 to 7 years;Pediatrics. Consilium Medicum;2024-02-27

3. Review of data sources used in real-world traumatology and orthopedic;Real-World Data & Evidence;2023-12-21

4. Real-world data in legal framework of the Russian Federation;Медицинская этика;2023-12

5. Overview of FDA guidelines for patient engagement in medical product development and regulatory decision making;Real-World Data & Evidence;2023-08-28